Selective Inhibitors of c-Jun N-terminal Kinases
Compositions and methods for treating, preventing, or ameliorating one or more symptoms, disorders, or conditions associated with particular c-Jun N-terminal kinase(s) (JNKs) activity are provided. Compositions contain small molecules such as pyrazoloanthrones.
WO 2,010,039,647 [MORE INFO
PANG YUAN-PING [US]; VUMMENTHALA ANURADHA [US]; PARK JEWN GIEW [US]; WANG SHAO-HUA [US]; DONG ZIGANG [US]; BODE ANN M [US]; CHO
Type of Offer:
« More Biotech Patents